PROMETHEUS BIOSCIENCES INC (RXDX) Earnings History & Surprises

NASDAQ:RXDX • US74349U1088

199.92 USD
+0.18 (+0.09%)
At close: Jun 15, 2023
199.95 USD
+0.03 (+0.02%)
After Hours: 6/15/2023, 8:23:19 PM

Past quarterly earnings results for PROMETHEUS BIOSCIENCES INC (RXDX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateN/A
PeriodQ2 / 2023
EPS Estimate-$0.95
Revenue Estimate616.08K

Last Reported

Most Recent
Release DateMay 9, 2023
PeriodQ1 / 2023
EPS Reported-$0.86
EPS Surprise 7.45%
Revenue Surprise 113.46%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -0.86 -0.93 7.45% -4.88% 1.105M 517.65K 113.46% -71.80%
Q4 2022 -0.90 -0.94 4.21% -16.88% 653K 590.692K 10.55% -37.03%
Q3 2022 -0.90 -0.92 2.44% -28.57% 968K 654.503K 47.90% -3.78%
Q2 2022 -0.86 -0.93 7.69% -75.51% 1.269M 520.649K 143.73% 289.26%
Q1 2022 -0.82 -0.81 -1.40% 50.90% 3.919M 669.293K 485.54% 415.66%
Q4 2021 -0.77 -0.69 -11.30% - 1.037M 554.584K 86.99% -
Q3 2021 -0.70 -0.60 -17.11% - 1.006M 357K 181.79% -
Q2 2021 -0.49 -0.40 -23.60% - 326K 153K 113.07% 82.12%
Q1 2021 -1.67 -0.38 -341.31% - 760K 204K 272.55% 233.33%
Q2 2020 - - 179K - -
Q1 2020 - - 228K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

RXDX EPS Q2Q GrowthRXDX EPS Q2Q GrowthEPS Q2Q Growth Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 20 -20 40 -40 -60

Revenue Historical Q2Q growth and Acceleration

RXDX Revenue Q2Q GrowthRXDX Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 100 200 300 400

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
5.45%
Max EPS beat (4)
7.69%
Min EPS beat (4)
2.44%

Revenue beat statistics

Revenue beat (4)
4
Average Revenue beat (4)
78.91%
Max Revenue beat (4)
143.73%
Min Revenue beat (4)
10.55%

Analysis

In the last 4 quarters, RXDX has consistently beaten EPS estimates in all releases
RXDX has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, RXDX has beaten the EPS estimates by 5.4% on average.
In the last 4 quarters, RXDX has beaten the revenue estimates by 78.9% on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

PROMETHEUS BIOSCIENCES INC / RXDX Earnings FAQ

Can you provide the last earnings date for PROMETHEUS BIOSCIENCES INC?

PROMETHEUS BIOSCIENCES INC (RXDX) last reported earnings on 5/9/2023.


Did RXDX stock beat earnings estimates in the most recent quarter?

PROMETHEUS BIOSCIENCES INC (RXDX) beat EPS estimates and beat revenue estimates in the most recent quarter.


Can you provide information on how often PROMETHEUS BIOSCIENCES INC beats earnings estimates?

In the last 4 quarters, PROMETHEUS BIOSCIENCES INC (RXDX) has beaten EPS estimates in 4 out of 4 releases.